United States · Bill · HR
H.R. 651 (100th)
A bill to provide that the effectiveness requirements of the Federal Food, Drug, and Cosmetic Act shall not apply to laetrile in certain cases.
Introduced
21 January 1987
Last action
—
Status
Referred to Subcommittee on Health and the Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Amends the Federal Food, Drug, and Cosmetic Act to exempt the use of laetrile for the treatment of pain under the direction of a physician from the effectiveness requirements of such Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
summary · EN · 21 January 1987
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/100th-congress/house-bill/651
- Open data entity: https://api.congress.gov/v3/bill/100/hr/651